RSS

Prostate cancer drugs could pose risk to heart health: FDA reviewing safety of anti-hormone treatments due to links with heart disease and diabetes.(MEDICAL THERAPY): An article from: Heart Advisor-Unavailable

  • Title: Prostate cancer drugs could pose risk to heart health: FDA reviewing safety of anti-hormone treatments due to links with heart disease and diabetes.(MEDICAL THERAPY): An article from: Heart Advisor
  • Author: Unavailable
  • Released: 0000-00-00
  • Language:
  • Pages: 0
  • ISBN:
  • ISBN13:
  • ASIN: B003ZCQUK4

DOWNLOAD CLICK HERE

Excerpt. © Reprinted by permission. All rights reserved.

The Food and Drug Administration (FDA) has announced that it is investigating the safety of gonadotropin-releasing hormone (GnRH) agonists, a class of drugs used to treat prostate cancer, after evidence linking them with a rise in the risk of heart disease and diabetes.

[ILLUSTRATION OMITTED]

It's not the first time concerns have been raised about the use of hormone therapy to treat prostate cancer--a 2009 study suggested it raises the risk of heart disease by as much as 25 percent, while other research suggests it may double the risk of metabolic syndrome, a cluster of risk factors linked to the development of heart disease, as well as cause declines in bone density.

pdf
 
0 Comment

Posted by